| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |